Lobbying Filing Details
Total Spending
$0
Activities
1
Lobbyists
2
Gov't Entities
3
Filing Information
- Filing UUID:
056a8e55-dd16-411c-9ef7-0c7da43c6028- Type:
- 2T - 2nd Quarter - Termination
- Period:
- 2026 - 2nd Quarter (Apr 1 - June 30)
- Date Posted:
- July 21, 2026 at 1:06 AM
- Income:
- $0
- Expenses:
- $0
- Termination Date:
- April 01, 2026
- Document URL:
- View Submission
Quick Info
- Document Type: text/html
- Posted By: Anusha Kumari
Registrant
THE VOGEL GROUP
Global lobbying and business advisory firm
Washington, District of ColumbiaClient
FORTRESS BIOTECH INC.
Biopharma venture studio that builds, funds, and manages a portfolio of drug-dev companies
Florida, United States of AmericaLobbying Activities (1)
Activity 1
Health IssuesGive kids a chance act H.R.1262; issues related to rare pediatric disease and priority review vouchers
Lobbyists (2)
- SAMIR N KAPADIA
- GREGOR LOBBYIST
Government Entities (3)
- SENATE
- HOUSE OF REPRESENTATIVES
- White House Office